SAMPSON, Peter Brent,LIU, Yong,LI, Sze-Wan,FORREST, Bryan T.,PAULS, Heinz W.,EDWARDS, Louise G.,FEHER, Miklos,PATEL, Narendra Kumar B.,LAUFER, Radoslaw,PAN, Guohua
申请号：
MEP26516
公开号：
ME02545B
申请日:
2011.04.06
申请国别(地区):
ME
年份:
2017
代理人:
摘要：
The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof: Compounds represented by this structural formula are kinase inhibitors and are therefore disclosed herein for the treatment of cancer. Definitions for the variables in the structural formula are provided herein.
